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Introduction
Sarcopenia is the progressive loss of muscle mass 
and strength which leads to the risk of outcomes such as 
poor quality of life, disability or death1. The prevalence 
of sarcopenia has been reported as 1-29% in community 
dwelling populations, 14-33% in long term care 
populations and 10% in one acute care population2. 
There is little consensus on prevalence mainly due to the 
different populations studied and methods used to diagnose 
sarcopenia2. The European Working Group on Sarcopenia 
in Older People (EWGSOP) have identified criteria for 
diagnosing sarcopenia: low muscle mass with low muscle 
strength or performance1. 
There are various methods that can be used to measure 
muscle mass. Magnetic Resonance Imaging (MRI) and 
Computed Tomography (CT) are very precise and are gold 
standard techniques for use in research1. The EWGSOP 
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states that dual x-ray absorptiometry (DXA) is the preferred 
alternative for both research and clinical use1. DXA 
measurements have been validated against MRI and CT and 
the difference has been found to be less than 5 percent3. Bio 
impedance analysis (BIA) is another method which is easier 
to access and use in a clinic setting. 
The diagnostic markers for sarcopenia: reduced strength, 
gait speed and muscle mass are also risk factors for falls4 
however there are only a few data available on the prevalence 
of sarcopenia in fallers. Studies have shown that there is 
a strong link between sarcopenia and falls. The ilSIRENTE 
study5 showed that 27.3% of participants diagnosed with 
sarcopenia during the study reported falls in the two year 
follow up of the study compared to only 9.8% of those 
without sarcopenia. Another study6 investigating older 
community dwelling participants in Japan also found that the 
prevalence of sarcopenia was higher in those who had fallen. 
Diagnosing sarcopenia in fallers is important as there are 
now interventions for sarcopenia available which may also 
help to reduce falls7-13.
This study aimed to determine the prevalence of 
sarcopenia in older people referred to a secondary care 
falls clinic.
Materials and methods
Ethical approval was gained prior to starting the study 
from NRES Committee East Midlands – Nottingham 2, 
reference 15/EM/0175. The population was taken from 
consecutive patients who had had falls or were at risk of 
falls and were receiving falls rehabilitation at the Nottingham 
University Hospitals Rehabilitation Unit (NUHRU) which is 
a secondary care falls rehabilitation unit. Recruitment was 
through provision of an information sheet about the study by 
the staff that usually see the patient at the unit. Participants 
were then approached by one of the research team if they 
had agreed to discuss the study and if consent was given 
they were recruited onto the study. 
Inclusion criteria were any person attending the NUHRU 
for rehabilitation due to falls or falls risk factors. Falls 
risk factors included reduced balance, muscle weakness, 
altered gait pattern, dizziness and visual deficit. Exclusion 
criteria were: Unable to complete the diagnostic tests; 
lacking capacity to consent to inclusion in the study; 
under 60 years of age.
This study used the EWGSOP method for diagnosing 
sarcopenia (low muscle mass and either reduced grip 
strength or low gait speed)1 for diagnosing sarcopenia. 
Gait speed was measured by 10 metre timed walk with a 
stop watch, participants used their usual walking aid. Grip 
strength was measured with a grip dynamometer (Jamar) 
and muscle mass was measured through BIA (Tanita bc-147 
machine14). As the Tanita machine measures and reports 
appendicular limb muscle mass, the Appendicular Skeletal 
Muscle Index (ASMI) was calculated by dividing appendicular 
skeletal muscle mass (sum of the muscle mass of the arms 
and legs) by height squared. The Rosetta study cut off points 
for muscle mass (7.26 kg/m2 for men and 5.45 kg/m2 for 
women) were employed3. The EWGSOP suggested cut-off 
points for gait speed and grip strength were used to diagnose 
reduced grip strength and low gait speed (Table 1).
Results
From a potential 103 participants the total sample size 
was 58, which included 22 males and 36 females (62.1%). 
Age range was 67-94 with the mean age (SD) being 80 (6.3) 
years old. Weight ranged from 45-110 kg with the mean 
weight (SD) being 71.9 (16.0) kg. Height ranged from 1.49-
1.85 metres with the mean height (SD) being 1.66 (0.1) 
metres. Fifty-five participants were fallers and 3 were at risk 
Outcome measure Cut off point
Grip strength:
Men 30 kg
Women 20 kg
Gait speed:
Men 0.8 m/s
Women 0.8 m/s
Muscle mass index:
Men 7.26 kg/m2
Women 5.45 kg/m2
Table 1. Cut-off points for outcome measures.
Diagram 1. Flow diagram showing the progress of participants 
through the study.
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of falls. When a potential participant was not recruited it was 
either due to them declining, being excluded from the study 
or due to them being discharged from the falls unit before 
they could be approached by the research team (Diagram 
1). Reasons for exclusion from the study were either lacking 
capacity to consent to inclusion in the study or being unable 
to complete the diagnostic tests due to poor mobility. 
Mean grip strength (SD) for women was 17.9 kg (4.9) 
and for men 29.9 kg (8.7). Mean gait speed (SD) for women 
was 0.61 m/s (0.2) and for men 0.72 m/s (0.4). 
Seven participants (12.0%) were unable to have BIA 
due to having a pacemaker or being unable to balance when 
standing on the machine. Mean ASMI (SD) was 6.98 kg/m2 
(1.0) for women and 7.85 kg/m2 (1.0) for men. 
Prevalence of sarcopenia in the total population was 
9.8% (95% CI=1.6%-18%; n=5). 
Of those diagnosed with sarcopenia 60% were male and 
80% were over the age of 80 years. 
Eleven participants had either Parkinson’s disease or 
a previous stroke but only one of these participants was 
sarcopenic. 
According to the BMI categories 2 participants (3.9%) 
were underweight (one of these was sarcopenic), 20 (39.2%) 
were normal in weight (with 15% being sarcopenic), 21 
(41.2%) were overweight (with 4.8% being sarcopenic), 
and 8 (15.7%) were obese (none being sarcopenic). 
Thirty-four participants used a walking aid and 14.7% 
of these were diagnosed with sarcopenia, conversely 17 
walked unaided and none of these were sarcopenic. 
Discussion
The results show that prevalence of sarcopenia, as 
measured by BIA, is not uncommon and accounts for 
around one tenth of older people referred to a secondary 
care falls clinic. This is important as sarcopenia is a risk 
factor for further falls and potential interventions for this 
condition are available. 
The most appropriate skeletal muscle index cut off points 
for this study were carefully considered. The EWGSOP 
paper suggests using 8.87 kg/m2 for men and 6.42 kg/
m2 for women1. However, these cut off points were derived 
from the Taiwanese study by Chien et al. (2008)15 in which 
they specifically used the BIA Janssen equation which 
was developed for estimating total skeletal muscle mass 
(SMM)16. Usually, 73-75% of total SMM is found within the 
limbs17. Therefore, it was felt that these cut off points were 
not appropriate for our study as the Tanita BIA device14 
estimated appendicular limb skeletal muscle mass (ASMM). 
This ASMM compartment can be estimated when a BIA 
equation is derived from a validation study where ASMM 
has been assessed using DXA. An example of this is the 
recent study by Sergi et al. where a new BIA equation was 
developed for older people using DXA as a reference18. In 
their paper, they discuss the prevalence of sarcopenia in the 
study population specifically using the Rosetta study cut off 
points (7.26 kg/m2 for men and 5.45 kg/m2 for women3). 
The Rosetta study cut off points have also been suggested 
as suitable cut off points using DXA estimation of ASMM 
by EWGSOP1. Therefore we chose the Rosetta Study cut off 
points as the most appropriate for the current study using 
Tanita BIA. The application of BIA and utilisation of specific 
cut off points for estimating sarcopenia is currently a ‘grey 
area’, which needs to be urgently addressed, as discussed in 
a recent editorial17.
A higher proportion of those with sarcopenia were male 
and over the age of 80 years. Prevalence of sarcopenia was 
lower with increasing BMI. Similar results have also been 
found in previous studies and it has been suggested that in 
older people over the age of 80 years, being underweight 
is an independent risk factor for sarcopenia19,20. However 
it is difficult to assess patterns of body composition from 
BMI21 as this method does not discriminate between body 
fat and lean mass22. An overweight or obese BMI may be due 
to increased lean mass rather than body fat and therefore 
a sarcopenia diagnosis would be less likely in this case. In 
those of low BMI however, nutritional interventions may be 
promising in treating sarcopenia7,9.
A limitation of this study was that although consecutive 
patients referred to the falls unit were approached, 
recruitment was difficult in this population as many declined 
to take part. Poor health and having too many hospital 
appointments were the main reasons cited for declining. 
The prevalence of sarcopenia therefore may have been 
underestimated in this population. 
Another limitation is that 11 participants had either 
Parkinson’s disease or a previous stroke which may have 
affected the results as these conditions can also cause 
muscle weakness and gait abnormalities. However this is 
representative of a falls clinic population and only one of 
these participants was sarcopenic. 
Using BIA to measure muscle mass was simple to perform 
in this setting and the majority of participants were able to 
use the machine, however further validation against gold 
standard methods of measuring muscle mass is needed in this 
population as accuracy has not been adequately established.
Conclusion
Sarcopenia, as measured by BIA is not uncommon in 
older people referred to a secondary care falls clinic. BIA was 
simple, relatively cheap and quick to perform in this busy falls 
clinic setting and shows promise in diagnosing sarcopenia, 
although further validation against gold standard methods 
is required in this population. As resistance exercise and 
nutritional interventions for treating sarcopenia are now 
being developed, simple methods for diagnosing sarcopenia 
in fallers such as BIA should be considered.
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